Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 38:
39. The compound of claim 38, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
at least one R2c is C1-C2 alkyl, wherein the C1-C2 alkyl is substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents;
each R4a is independently halogen, NR8C(O)OR10, phenyl, or 6-membered heteroaryl, wherein each phenyl and 6-membered heteroaryl is optionally and independently substituted by 1, 2, 3, 4, or 5 independently selected R4b substituents; and
each R4b is an independently selected halogen substituent.